Early diagnosis and vigilant screening are critical for optimizing sarcoma treatment, as patients are often healthiest at initial presentation. CU Cancer Center Breelyn Wilky, MD, highlights the importance of multidisciplinary care and innovative clinical trials to improve outcomes for this rare cancer.